Ergoteles LLC Vor Biopharma Inc. Transaction History
Ergoteles LLC
- $68.2 Billion
- Q3 2023
Shares
4 transactions
Others Institutions Holding VOR
# of Institutions
73Shares Held
47.9MCall Options Held
1.5KPut Options Held
0-
Ra Capital Management, L.P. Boston, MA22.7MShares$15.9 Million0.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.46MShares$4.52 Million0.26% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$4.45 Million2.98% of portfolio
-
Laurion Capital Management LP New York, NY2.53MShares$1.77 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.37 Million0.0% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $26.6M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...